Fan et al. demonstrated on an ESCC rat model induced with N-nitroso-N-methylbenzylamine (NMBzA) that metformin reduced esophageal inflammation and carcinogenesis by suppressing iNOS, COX-2 and IL-6 expressions. This evidence concerns the gene PTGS2 and esophageal squamous cell carcinoma.